Abstract Background Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene. ErbB1 encodes epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, involved mainly in cell proliferation and survival. EGFR overexpression has been associated with more aggressive disease, poor prognosis, low survival rate and low response to therapy. ErbB1 amplification and mutation are associated with tumor development and are implicated in ineffective treatment. The aim of the present study was to investigate whether the ErbB1 copy number affects EGFR expression, cell proliferation or cell migration by comparing two different cell lines. ...
IntroductionPatients with non-small cell lung cancer (NSCLC) with cancers harboring activating mutat...
[[abstract]]To evaluate the association of epidermal growth factor receptor (EGFR) gene copy number ...
Aims: Overexpression and mutation of epidermal growth factor regulator (EGFR) are frequently found i...
Abstract Background Lung cancer often exhibits molecu...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
Lung cancer is the most common type of cancer in men and women worldwide, and it is the main cause o...
Summar- ErbB-2 and EGFR (epidermal growth factor receptor) are expressed in lung adenocarcinomas and...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mut...
AbstractOBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal...
Prognosis for patients with non-small cell lung cancer (NSCLC) is poor. The potential value of modu...
The ErbB receptor tyrosine kinases play important roles in normal physiology and in cancer. Epiderma...
The Epidermal Growth Factor Receptor (EGFR) is associated with a variety of cancers, including brain...
There are seven ligands for the epidermal growth factor receptor (EGFR) ErbB1 and two ligands for Er...
IntroductionPatients with non-small cell lung cancer (NSCLC) with cancers harboring activating mutat...
[[abstract]]To evaluate the association of epidermal growth factor receptor (EGFR) gene copy number ...
Aims: Overexpression and mutation of epidermal growth factor regulator (EGFR) are frequently found i...
Abstract Background Lung cancer often exhibits molecu...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
To clarify the pathogenic and biological significance of EGFR mutations in lung cancer, we compared ...
Lung cancer is the most common type of cancer in men and women worldwide, and it is the main cause o...
Summar- ErbB-2 and EGFR (epidermal growth factor receptor) are expressed in lung adenocarcinomas and...
[[abstract]]Controlled activation of epidermal growth factor receptor (EGFR) is systematically guara...
Introduction: Patients with non-small cell lung cancer (NSCLC) with cancers harboring activating mut...
AbstractOBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal...
Prognosis for patients with non-small cell lung cancer (NSCLC) is poor. The potential value of modu...
The ErbB receptor tyrosine kinases play important roles in normal physiology and in cancer. Epiderma...
The Epidermal Growth Factor Receptor (EGFR) is associated with a variety of cancers, including brain...
There are seven ligands for the epidermal growth factor receptor (EGFR) ErbB1 and two ligands for Er...
IntroductionPatients with non-small cell lung cancer (NSCLC) with cancers harboring activating mutat...
[[abstract]]To evaluate the association of epidermal growth factor receptor (EGFR) gene copy number ...
Aims: Overexpression and mutation of epidermal growth factor regulator (EGFR) are frequently found i...